$1.47
18.55% yesterday
Nasdaq, Aug 27, 10:28 pm CET
ISIN
US7743741024
Symbol
RMTI

Rockwell Medical, Inc. Stock price

$1.47
+0.44 42.72% 1M
-0.16 9.82% 6M
-0.57 27.94% YTD
-1.60 52.12% 1Y
+0.05 3.52% 3Y
-13.60 90.25% 5Y
-129.98 98.88% 10Y
-33.84 95.84% 20Y
Nasdaq, Closing price Wed, Aug 27 2025
+0.23 18.55%

Key metrics

Basic
Market capitalization
$50.6m
Enterprise Value
$42.7m
Net debt
positive
Cash
$18.4m
Shares outstanding
34.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.6 | 0.7
EV/Sales
0.5 | 0.6
EV/FCF
15.9
P/B
1.7
Financial Health
Equity Ratio
55.0%
Return on Equity
-1.5%
ROCE
-3.1%
ROIC
-
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
$88.0m | $69.7m
EBITDA
$900.0k | $-2.9m
EBIT
$-1.3m | $-6.0m
Net Income
$-2.1m | $-6.2m
Free Cash Flow
$2.7m
Growth (TTM | estimate)
Revenue
-6.8% | -31.3%
EBITDA
202.3% | -203.3%
EBIT
58.2% | -1,091.3%
Net Income
56.0% | -1,181.3%
Free Cash Flow
115.3%
Margin (TTM | estimate)
Gross
17.5%
EBITDA
1.0% | -4.1%
EBIT
-1.5%
Net
-2.4% | -8.8%
Free Cash Flow
3.1%
More
EPS
$-0.1
FCF per Share
$0.1
Short interest
0.3%
Employees
244
Rev per Employee
$420.0k
Show more

Is Rockwell Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Rockwell Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Rockwell Medical, Inc. forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Rockwell Medical, Inc. forecast:

Buy
88%
Hold
13%

Financial data from Rockwell Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
88 88
7% 7%
100%
- Direct Costs 73 73
11% 11%
82%
15 15
22% 22%
18%
- Selling and Administrative Expenses 17 17
11% 11%
19%
- Research and Development Expense - -
-
-
0.90 0.90
202% 202%
1%
- Depreciation and Amortization 2.19 2.19
1% 1%
2%
EBIT (Operating Income) EBIT -1.29 -1.29
58% 58%
-1%
Net Profit -2.10 -2.10
56% 56%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about Rockwell Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Rockwell Medical, Inc. Stock News

Neutral
The Motley Fool
14 days ago
Image source: The Motley Fool.
Neutral
Seeking Alpha
14 days ago
Rockwell Medical, Inc. (NASDAQ:RMTI ) Q2 2025 Earnings Conference Call August 14, 2025 8:00 AM ET Company Participants Heather H. Hunter - Senior VP & Chief Corporate Affairs Officer Jesse Neri - Senior VP & CFO Mark Strobeck - President, CEO & Director Conference Call Participants Jeremy Pearlman - Maxim Group LLC, Research Division Raghuram Selvaraju - H.C.
Neutral
Business Wire
14 days ago
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces financial and operational results for the three and six months ended June 30, 2025.
More Rockwell Medical, Inc. News

Company Profile

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Hackensack, NJ.

Head office United States
CEO Mark Strobeck
Employees 244
Founded 1995
Website www.rockwellmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today